My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BridgeBio Pharma, Inc. - Common Stock (NQ:BBIO)

68.14 -2.58 (-3.65%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BridgeBio Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 12, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 11, 2023

Via Benzinga

BioMarin Presents ~20% Upside Amid Voxzogo's Success and Slow Roctavian Uptake, Analyst Says ↗

July 05, 2023

BMO Capital Markets has upgraded BioMarin Pharmaceutical Inc (NASDAQ: BMRN) to Outperform from Market Perform, and the price target remains at $102,

Via Benzinga

2 Growth Stocks With Major Incoming Catalysts ↗

June 27, 2023

Binary events slated for July could quickly send these biotech stocks through the roof.

Via The Motley Fool

Why BridgeBio Pharma Stock Is Plunging Today ↗

June 15, 2023

A cautionary note from JPMorgan is weighing on the biotech's shares today.

Via The Motley Fool

BridgeBio Pharma: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About BridgeBio Pharma ↗

April 13, 2023

Via Benzinga

2 Best Growth Stocks to Buy in April ↗

April 03, 2023

Takeover interest is spurring these two biotech stocks higher.

Via The Motley Fool

4 Analysts Have This to Say About BridgeBio Pharma ↗

March 07, 2023

Via Benzinga

Second Quarter Outlook For Biotech Stocks ↗

April 25, 2023

Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity.

Via Talk Markets

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023 ↗

April 19, 2023

Via Benzinga

Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns ↗

March 31, 2023

The first quarter of 2023 was positive for the U.S. stock market as a whole, with the S&P 500 index faithfully tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), rising by 6%.

Via Benzinga

Stocks Rise As Investors Bet On Bank Recovery ↗

March 29, 2023

Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.

Via Talk Markets

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories ↗

March 27, 2023

Benzinga

Via Benzinga

Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest ↗

March 27, 2023

BridgeBio Pharma Inc (NASDAQ: BBIO) is reportedly attracting takeover interest as some large pharmaceutical companies are studying a potential acquisition of the biotech firm.

Via Benzinga

First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 27, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why BridgeBio Pharma Shares Are Falling Sharply ↗

March 08, 2023

BridgeBio Pharma Inc (NASDAQ: BBIO) shares are trading lower by 15.8% to $15.62 Wednesday morning after the company priced an offering of 8.82 million shares at $17 per share.

Via Benzinga

After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use ↗

March 08, 2023

Via Benzinga

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗

March 07, 2023

Via Benzinga

Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗

March 07, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

March 06, 2023

Via Benzinga

Why BioMarin Shares Are Plunging Today? ↗

March 06, 2023

Biomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug, heating the competition.

Via Benzinga

These 2 Biotech Stocks Made Big Monday Moves ↗

March 06, 2023

Find out which was the winner and which was the loser.

Via The Motley Fool

Nasdaq Rises 50 Points; Ciena Earnings Top Expectations ↗

March 06, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday. The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P...

Via Benzinga

Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 06, 2023

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 06, 2023

Via Benzinga

Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher ↗

March 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500...

Via Benzinga

Why BridgeBio Pharma Stock Is Skyrocketing Today ↗

March 06, 2023

BridgeBio's latest results could set the bar in efficacy for treating the most common cause of short stature.

Via The Motley Fool

Stocks Rise As Bond Yields Fall; Investors Await Economic Data ↗

March 06, 2023

Wall Street is starting the week higher, as investors look ahead to upcoming economic data and new commentary from the Federal Reserve.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.